Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-28T10:41:37.674Z Has data issue: false hasContentIssue false
  • English
  • Français

Pharmacological treatment of early psychosis: risks and benefits

Published online by Cambridge University Press:  19 July 2023

L. Sīle
L. Sīle*
Affiliation:
1Research and education department, Rigas Centre of Psychiatry and Addiction medicine 2Psychiatry and Addiction medicine, Rigas Stardins University, Riga, Latvia

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Abstract

Psychiatry has changed a lot during the last decades and lot of effort has been made to ensure that treatment of schizophrenia spectrum disorders is in line with modern science of medicine. Therefore, in everyday practice the psychiatrist is in a constant process of decision making when to start pharmacological treatment of early psychosis and with what dosage. The lecture will include evidence-based treatment options, the aspects of clinical practice and the power of shared decision-making in psychiatry.

Disclosure of Interest

None Declared

Type
Abstract
Information
European Psychiatry , Volume 66 , Special Issue S1: Abstracts of the 31st European Congress of Psychiatry , March 2023 , pp. S31
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.